9729 |
Ab00103-10.6-BT |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
1 mg |
支 |
21540.00 |
9730 |
Ab00103-10.6 |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
200 μg |
支 |
5460.00 |
9731 |
Ab00103-10.3-BT |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
1 mg |
支 |
19920.00 |
9732 |
Ab00103-10.3 |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
200 μg |
支 |
4680.00 |
9733 |
Ab00103-10.0-BT |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
1 mg |
支 |
19920.00 |
9734 |
Ab00103-10.0 |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
200 μg |
支 |
4680.00 |
9735 |
Ab00102-9.4-BT |
Anti-Fluorescein [4-4-20 (enhanced)] |
1 mg |
支 |
19920.00 |
9736 |
Ab00102-9.4 |
Anti-Fluorescein [4-4-20 (enhanced)] |
200 μg |
支 |
4680.00 |
9737 |
Ab00102-9.1-BT |
Anti-Fluorescein [4-4-20 (enhanced)] |
1 mg |
支 |
19920.00 |
9738 |
Ab00102-9.1 |
Anti-Fluorescein [4-4-20 (enhanced)] |
200 μg |
支 |
4680.00 |
9739 |
Ab00102-8.4-BT |
Anti-Fluorescein [4-4-20 (enhanced)] |
1 mg |
支 |
19920.00 |
9740 |
Ab00102-8.4 |
Anti-Fluorescein [4-4-20 (enhanced)] |
200 μg |
支 |
4680.00 |
9741 |
Ab00102-8.2-BT |
Anti-Fluorescein [4-4-20 (enhanced)] |
1 mg |
支 |
19920.00 |
9742 |
Ab00102-8.2 |
Anti-Fluorescein [4-4-20 (enhanced)] |
200 μg |
支 |
4680.00 |
9743 |
Ab00102-8.1-BT |
Anti-Fluorescein [4-4-20 (enhanced)] |
1 mg |
支 |
19920.00 |
9744 |
Ab00102-8.1 |
Anti-Fluorescein [4-4-20 (enhanced)] |
200 μg |
支 |
4680.00 |